Goodman & Gilman's The pharmacological basis of therapeutics:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
New York [u.a.]
McGraw-Hill
2006
|
Ausgabe: | 11. ed. |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | XXIII, 2021 S. Ill., graph. Darst. |
ISBN: | 0071422803 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV020820122 | ||
003 | DE-604 | ||
005 | 20160218 | ||
007 | t | ||
008 | 051005s2006 ad|| |||| 00||| eng d | ||
020 | |a 0071422803 |9 0-07-142280-3 | ||
035 | |a (OCoLC)254787784 | ||
035 | |a (DE-599)BVBBV020820122 | ||
040 | |a DE-604 |b ger |e rakwb | ||
041 | 0 | |a eng | |
049 | |a DE-355 |a DE-19 |a DE-20 |a DE-29 |a DE-188 | ||
050 | 0 | |a RM300 | |
082 | 0 | |a 615.7 | |
084 | |a XI 1300 |0 (DE-625)152972: |2 rvk | ||
245 | 1 | 0 | |a Goodman & Gilman's The pharmacological basis of therapeutics |c ed. Laurence L. Brunton |
246 | 1 | 3 | |a Goodman and Gilman's The pharmacological basis of therapeutics |
246 | 1 | 3 | |a The pharmacological basis of therapeutics |
250 | |a 11. ed. | ||
264 | 1 | |a New York [u.a.] |b McGraw-Hill |c 2006 | |
300 | |a XXIII, 2021 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
650 | 4 | |a Pharmacology | |
650 | 4 | |a Therapeutics | |
650 | 0 | 7 | |a Toxikologie |0 (DE-588)4060538-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Klinische Pharmakologie |0 (DE-588)4073517-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittel |0 (DE-588)4003115-9 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4151278-9 |a Einführung |2 gnd-content | |
655 | 4 | |a Einführung - Pharmakotherapie | |
689 | 0 | 0 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Toxikologie |0 (DE-588)4060538-3 |D s |
689 | 1 | |8 1\p |5 DE-604 | |
689 | 2 | 0 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
689 | 2 | |8 2\p |5 DE-604 | |
689 | 3 | 0 | |a Arzneimittel |0 (DE-588)4003115-9 |D s |
689 | 3 | |8 3\p |5 DE-604 | |
689 | 4 | 0 | |a Klinische Pharmakologie |0 (DE-588)4073517-5 |D s |
689 | 4 | |8 4\p |5 DE-604 | |
700 | 1 | |a Brunton, Laurence L. |e Sonstige |0 (DE-588)137411162 |4 oth | |
700 | 1 | |a Goodman, Louis Sanford |d 1906-2000 |e Sonstige |0 (DE-588)132895110 |4 oth | |
700 | 1 | |a Gilman, Alfred |d 1908-1984 |e Sonstige |0 (DE-588)132895021 |4 oth | |
856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013525503&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-013525503 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 4\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk |
Datensatz im Suchindex
_version_ | 1804133773008175104 |
---|---|
adam_text | CONTENTS
Contributors / xi
Consultants to the Editors / xvii
Preface / xxi
Preface to the First Edition / xxiii
SECTION I
GENERAL PRINCIPLES 1
1. Pharmacokinetics and Pharmacodynamics: The Dynamics of Drug Absorption,
Distribution, Action, and Elimination / 1
lain L. O. Buxton
2. Membrane Transporters and Drug Response / 41
Kathleen M. Ciacomini and Yuichi Sugiyama
3. Drug Metabolism / 71
Frank J. Gonzalez and Robert H. Tukey
4. Pharmacogenetics / 93
Mary V. Relling and Kathleen M. Ciacomini
5. The Science of Drug Therapy / 117
John A Oates
SECTION II
DRUGS ACTING AT SYNAPTIC AND NEUROEFFECTOR JUNCTIONAL SITES 137
6. Neurotransmission: The Autonomic and Somatic Motor Nervous Systems / 137
Thomas C. Westfall and David P. Westfall
7. Muscarinic Receptor Agonists and Antagonists / 183
Joan Heller Brown and Palmer Taylor
8. Anticholinesterase Agents / 201
Palmer Taylor
9. Agents Acting at the Neuromuscular Junction and Autonomic Ganglia / 217
Palmer Taylor
10. Adrenergic Agonists and Antagonists / 237
Thomas C Westfall and David P. Westfall
vi Contents
11. 5 Hydroxytryptamine (Serotonin): Receptor Agonists
and Antagonists / 297
Elaine Sanders Bush and Steven E. Mayer
SECTION III
DRUGS ACTING ON THE CENTRAL NERVOUS SYSTEM 317
12. Neurotransmission and the Central Nervous System / 317
Floyd f. Bloom
13. General Anesthetics / 341
Alex S. Evers, C Michael Crowder, and Jeffrey R. Balser
14. Local Anesthetics / 369
William A. Catterall and Ken Mackie
15. Therapeutic Gases: Oxygen, Carbon Dioxide, Nitric Oxide, and Helium / 387
Brett A. Simon, Eric). Moody, and Roger A. Johns
16. Hypnotics and Sedatives / 401
Dennis S. Charney, S. John Mihic, and R. Adron Harris
17. Drug Therapy of Depression and Anxiety Disorders / 429
Ross J. Baldessarini
18. Pharmacotherapy of Psychosis and Mania / 461
Ross J. Baldessarini and Frank I. Tarazi
19. Pharmacotherapy of the Epilepsies / 501
James O. McNamara
20. Treatment of Central Nervous System Degenerative Disorders / 527
David C. Standaert and Anne B. Young
21. Opioid Analgesics / 547
Howard B. Cutstein and Huda Akil
22. Ethanol / 591
Michael F. Fleming, S. John Mihic, and R. Adron Harris
23. Drug Addiction and Drug Abuse / 607
Charles P. O Brien
SECTION IV
AUTACOIDS: DRUG THERAPY OF INFLAMMATION 629
24. Histamine, Bradykinin, and Their Antagonists / 629
Randal A. Skidgel and Ervin C. Erdo s
Contents vii
25. Lipid Derived Autacoids: Eicosanoids and Platelet Activating Factor / 653
Emer M. Smyth, Anne Burke, and Garret A. FitzGerald
26. Analgesic Antipyretic Agents; Pharmacotherapy of Gout / 671
Anne Burke, Emer M. Smyth, and Garret A. FitzGerald
27. Pharmacotherapy of Asthma / 717
Bradley J. Undem
SECTION V
DRUGS AFFECTING RENAL AND CARDIOVASCULAR FUNCTION 737
28. Diuretics / 737
Edwin K. Jackson
29. Vasopressin and Other Agents Affecting the Renal Conservation of Water / 771
Edwin K. Jackson
30. Renin and Angiotensin / 789
Edwin K. Jackson
31. Treatment of Myocardial Ischemia / 823
Thomas Michel
32. Therapy of Hypertension / 845
Brian B. Hoffman
33. Pharmacotherapy of Congestive Heart Failure / 869
Thomas P. Rocco and James C. Fang
34. Antiarrhythmic Drugs / 899
DanM. Roden
35. Drug Therapy for Hypercholesterolemia and Dyslipidemia / 933
Robert W. Mahley and Thomas P. Bersot
SECTION VI
DRUGS AFFECTING GASTROINTESTINAL FUNCTION 967
36. Pharmacotherapy of Gastric Acidity, Peptic Ulcers, and Gastroesophageal
Reflux Disease / 967
Willemijntje A. Hoogerwerf and PankajJay Pasricha
37. Treatment of Disorders of Bowel Motility and Water Flux; Antiemetics;
Agents Used in Biliary and Pancreatic Disease / 983
Pankaj Jay Pasricha
38. Pharmacotherapy of Inflammatory Bowel Disease / 1009
Joseph H. Sellin and Pankaj Jay Pasricha
viii Contents
SECTION VII
CHEMOTHERAPY OF PARASITIC INFECTIONS 1021
39. Chemotherapy of Protozoal Infections: Malaria / 1021
Theresa A Shapiro and Daniel £ Goldberg
40. Chemotherapy of Protozoal Infections: Amebiasis, Giardiasis, Trichomoniasis,
Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections / 1049
Margaret A. Phillips and Samuel L Stanley, Jr.
41. Chemotherapy of Helminth Infections / 1073
Alex Loukas and Peter J. Hotez
SECTION VIII
CHEMOTHERAPY OF MICROBIAL DISEASES 1095
42. General Considerations of Antimicrobial Therapy / 1095
Henry F. Chambers
43. Sulfonamides, Trimethoprim Sulfamethoxazole, Quinolones, and Agents
for Urinary Tract Infections / 1111
William A. Petri, Jr.
44. Penicillins, Cephalosporins, and Other /3 Lactam Antibiotics / 1127
William A Petri, Jr.
45. Aminoglycosides / 1155
Henry F. Chambers
46. Protein Synthesis Inhibitors and Miscellaneous Antibacterial Agents / 1173
Henry F. Chambers
47. Chemotherapy of Tuberculosis, Mycobacterium avium Complex Disease,
and Leprosy / 1203
William A. Petri, Jr.
48. Antifungal Agents / 1225
John f. Bennett
49. Antiviral Agents (Nonretroviral) / 1243
Frederick G. Hayden
50. Antiretroviral Agents and Treatment of HIV Infection / 1273
Charles Flexner
Contents ix
SECTION IX
CHEMOTHERAPY OF NEOPLASTIC DISEASES 1315
51. Antineoplastic Agents / 1315
Bruce A Chabner, Philip C. Amrein, Brian Druker, M. Dror Michaelson, Constantine S. Mitsiades, Paul E. Coss, David P. Ryan,
Sumant Ramachandra, Paul C. Richardson, Jeffrey C. Supko, and Wyndham H. Wilson
SECTION X
IMMUNOMODULATORS 1405
52. Immunosuppressants, Tolerogens, and Immunostimulants / 1405
Alan M. Krensky, Flavio Vincenti, and William M. Bennett
SECTION XI
DRUGS ACTING ON THE BLOOD AND THE BLOOD FORMING ORGANS 1433
53. Hematopoietic Agents: Growth Factors, Minerals, and Vitamins / 1433
Kenneth Kaushansky and Thomas J. Kipps
54. Blood Coagulation and Anticoagulant, Thrombolytic, and Antiplatelet Drugs / 1467
Philip W. Majerus and Douglas M. Tollefsen
SECTION XII
HORMONES AND HORMONE ANTAGONISTS 1489
55. Pituitary Hormones and Their Hypothalamic Releasing Factors / 1489
Keith L Parker and Bernard P. Schimmer
56. Thyroid and Antithyroid Drugs / 1511
Alan P. Farwell and Lewis £ Braverman
57. Estrogens and Progestins / 1541
David S. Loose and George M. Stancel
58. Androgens / 1573
Peter J. Snyder
59. Adrenocorticotropic Hormone; Adrenocortical Steroids and Their Synthetic Analogs;
Inhibitors of the Synthesis and Actions of Adrenocortical Hormones / 1587
Bernard P. Schimmer and Keith L. Parker
x Contents
60. Insulin, Oral Hypoglycemic Agents, and the Pharmacology of the
Endocrine Pancreas / 1613
Stephen N. Davis
61. Agents Affecting Mineral Ion Homeostasis and Bone Turnover / 1647
Peter A. Friedman
SECTION XIII
DERMATOLOGY 1679
62. Dermatological Pharmacology / 1679
Lindy P. Fox, Hans F. Merk, and David R. Bickers
SECTION XIV
OPHTHALMOLOGY 1707
63. Ocular Pharmacology / 1707
Jeffrey D. Henderer and Christopher J. Rapuano
SECTION XV
TOXICOLOGY 1739
64. Principles of Toxicology and Treatment of Poisoning / 1739
Curtis D. Klaassen
65. Heavy Metals and Heavy Metal Antagonists / 1753
Curtis D. Klaassen
APPENDICES
I. Principles of Prescription Order Writing and Patient Compliance / 1777
lain L O. Buxton
II. Design and Optimization of Dosage Regimens; Pharmacokinetic Data / 1787
Kenneth E. Thummel, Danny D. Shen, Nina Isoherranen, and Helen E. Smith
Index / 1889
|
any_adam_object | 1 |
author_GND | (DE-588)137411162 (DE-588)132895110 (DE-588)132895021 |
building | Verbundindex |
bvnumber | BV020820122 |
callnumber-first | R - Medicine |
callnumber-label | RM300 |
callnumber-raw | RM300 |
callnumber-search | RM300 |
callnumber-sort | RM 3300 |
callnumber-subject | RM - Therapeutics and Pharmacology |
classification_rvk | XI 1300 |
ctrlnum | (OCoLC)254787784 (DE-599)BVBBV020820122 |
dewey-full | 615.7 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.7 |
dewey-search | 615.7 |
dewey-sort | 3615.7 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
edition | 11. ed. |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02710nam a2200637 c 4500</leader><controlfield tag="001">BV020820122</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20160218 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">051005s2006 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0071422803</subfield><subfield code="9">0-07-142280-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)254787784</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV020820122</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM300</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.7</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 1300</subfield><subfield code="0">(DE-625)152972:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Goodman & Gilman's The pharmacological basis of therapeutics</subfield><subfield code="c">ed. Laurence L. Brunton</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Goodman and Gilman's The pharmacological basis of therapeutics</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">The pharmacological basis of therapeutics</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">11. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York [u.a.]</subfield><subfield code="b">McGraw-Hill</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXIII, 2021 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Therapeutics</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Toxikologie</subfield><subfield code="0">(DE-588)4060538-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Klinische Pharmakologie</subfield><subfield code="0">(DE-588)4073517-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4151278-9</subfield><subfield code="a">Einführung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Einführung - Pharmakotherapie</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Toxikologie</subfield><subfield code="0">(DE-588)4060538-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Arzneimittel</subfield><subfield code="0">(DE-588)4003115-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Klinische Pharmakologie</subfield><subfield code="0">(DE-588)4073517-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="8">4\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brunton, Laurence L.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)137411162</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Goodman, Louis Sanford</subfield><subfield code="d">1906-2000</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)132895110</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gilman, Alfred</subfield><subfield code="d">1908-1984</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)132895021</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013525503&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-013525503</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
genre | (DE-588)4151278-9 Einführung gnd-content Einführung - Pharmakotherapie |
genre_facet | Einführung Einführung - Pharmakotherapie |
id | DE-604.BV020820122 |
illustrated | Illustrated |
indexdate | 2024-07-09T20:14:02Z |
institution | BVB |
isbn | 0071422803 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-013525503 |
oclc_num | 254787784 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-20 DE-29 DE-188 |
owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM DE-20 DE-29 DE-188 |
physical | XXIII, 2021 S. Ill., graph. Darst. |
publishDate | 2006 |
publishDateSearch | 2006 |
publishDateSort | 2006 |
publisher | McGraw-Hill |
record_format | marc |
spelling | Goodman & Gilman's The pharmacological basis of therapeutics ed. Laurence L. Brunton Goodman and Gilman's The pharmacological basis of therapeutics The pharmacological basis of therapeutics 11. ed. New York [u.a.] McGraw-Hill 2006 XXIII, 2021 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Pharmacology Therapeutics Toxikologie (DE-588)4060538-3 gnd rswk-swf Klinische Pharmakologie (DE-588)4073517-5 gnd rswk-swf Arzneimittel (DE-588)4003115-9 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf (DE-588)4151278-9 Einführung gnd-content Einführung - Pharmakotherapie Pharmakotherapie (DE-588)4076066-2 s DE-604 Toxikologie (DE-588)4060538-3 s 1\p DE-604 Pharmakologie (DE-588)4045687-0 s 2\p DE-604 Arzneimittel (DE-588)4003115-9 s 3\p DE-604 Klinische Pharmakologie (DE-588)4073517-5 s 4\p DE-604 Brunton, Laurence L. Sonstige (DE-588)137411162 oth Goodman, Louis Sanford 1906-2000 Sonstige (DE-588)132895110 oth Gilman, Alfred 1908-1984 Sonstige (DE-588)132895021 oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013525503&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 4\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Goodman & Gilman's The pharmacological basis of therapeutics Pharmacology Therapeutics Toxikologie (DE-588)4060538-3 gnd Klinische Pharmakologie (DE-588)4073517-5 gnd Arzneimittel (DE-588)4003115-9 gnd Pharmakotherapie (DE-588)4076066-2 gnd Pharmakologie (DE-588)4045687-0 gnd |
subject_GND | (DE-588)4060538-3 (DE-588)4073517-5 (DE-588)4003115-9 (DE-588)4076066-2 (DE-588)4045687-0 (DE-588)4151278-9 |
title | Goodman & Gilman's The pharmacological basis of therapeutics |
title_alt | Goodman and Gilman's The pharmacological basis of therapeutics The pharmacological basis of therapeutics |
title_auth | Goodman & Gilman's The pharmacological basis of therapeutics |
title_exact_search | Goodman & Gilman's The pharmacological basis of therapeutics |
title_full | Goodman & Gilman's The pharmacological basis of therapeutics ed. Laurence L. Brunton |
title_fullStr | Goodman & Gilman's The pharmacological basis of therapeutics ed. Laurence L. Brunton |
title_full_unstemmed | Goodman & Gilman's The pharmacological basis of therapeutics ed. Laurence L. Brunton |
title_short | Goodman & Gilman's The pharmacological basis of therapeutics |
title_sort | goodman gilman s the pharmacological basis of therapeutics |
topic | Pharmacology Therapeutics Toxikologie (DE-588)4060538-3 gnd Klinische Pharmakologie (DE-588)4073517-5 gnd Arzneimittel (DE-588)4003115-9 gnd Pharmakotherapie (DE-588)4076066-2 gnd Pharmakologie (DE-588)4045687-0 gnd |
topic_facet | Pharmacology Therapeutics Toxikologie Klinische Pharmakologie Arzneimittel Pharmakotherapie Pharmakologie Einführung Einführung - Pharmakotherapie |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013525503&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT bruntonlaurencel goodmangilmansthepharmacologicalbasisoftherapeutics AT goodmanlouissanford goodmangilmansthepharmacologicalbasisoftherapeutics AT gilmanalfred goodmangilmansthepharmacologicalbasisoftherapeutics AT bruntonlaurencel goodmanandgilmansthepharmacologicalbasisoftherapeutics AT goodmanlouissanford goodmanandgilmansthepharmacologicalbasisoftherapeutics AT gilmanalfred goodmanandgilmansthepharmacologicalbasisoftherapeutics AT bruntonlaurencel thepharmacologicalbasisoftherapeutics AT goodmanlouissanford thepharmacologicalbasisoftherapeutics AT gilmanalfred thepharmacologicalbasisoftherapeutics |